Issue
Alert me when new journal issues are available via or via
Masthead page IFC Full-Text PDF (33 KB)
Editorial Board page i Full-Text PDF (58 KB)
Contents pages ii-iii Full-Text PDF (47 KB)
News and Topics
Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer Stacy Loeb, H. Ballentine Carter pages 583-584 Full Text | Full-Text PDF (83 KB)
Review Article
Friend or foe? Role of peroxisome proliferator-activated receptor-γ in human bladder cancer, 23 January 2009 Teruo Inamoto, Jay B. Shah, Ashish M. Kamat pages 585-591 Abstract | Full Text | Full-Text PDF (204 KB)
Original Articles
Prognostic significance of prostate cancer originating from the transition zone, 17 September 2008 Christopher R. King, Michelle Ferrari, James D. Brooks pages 592-597 Abstract | Full Text | Full-Text PDF (538 KB)
Clinical outcome of combined immunotherapy with interferon-α and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma, 26 September 2008 Hideaki Miyake, Toshifumi Kurahashi, Atsushi Takenaka, Taka-aki Inoue, Masato Fujisawa pages 598-603 Abstract | Full Text | Full-Text PDF (334 KB)
Treatment of a population based sample of men diagnosed with testicular cancer in the United States, 17 September 2008 Michael Osswald, Linda C. Harlan, David Penson, Jennifer L. Stevens, Limin X. Clegg pages 604-610 Abstract | Full Text | Full-Text PDF (176 KB)
Upper urinary tract dilation due to conglutination of intraluminal distal ureters after orthotopic neobladder with split-cuff nipple ureteral reimplants: Early results of 8 cases, 17 April 2009 Kai Yao, Guo-Liang Hou, Zhuo-Wei Liu, Shao-Long Yu, Yong-Hong Li, Fang-jian Zhou pages 611-616 Abstract | Full Text | Full-Text PDF (235 KB)
Seminar Section Introduction
Geriatric urologic oncology: A field coming of age PierFrancesco Bassi pages 617-619 Full Text | Full-Text PDF (102 KB)
Seminar Articles
Cancer and aging: The molecular pathways PierFrancesco Bassi, Emilio Sacco pages 620-627 Abstract | Full Text | Full-Text PDF (218 KB)
Surgical considerations for elderly urologic oncology patients Anne K. Schuckman, John P. Stein, Donald Skinner pages 628-632 Abstract | Full Text | Full-Text PDF (147 KB)
Cancer chemotherapy in the older cancer patient Ignazio Carreca, Lodovico Balducci pages 633-642 Abstract | Full Text | Full-Text PDF (966 KB)
Radiation therapy for urologic malignancies in the elderly Ajay Sandhu, Arno J. Mundt pages 643-652 Abstract | Full Text | Full-Text PDF (1309 KB)
Bladder cancer in the elderly Shahrokh F. Shariat, Matthew Milowsky, Michael J. Droller pages 653-667 Abstract | Full Text | Full-Text PDF (411 KB)
Prostate cancer in the elderly Hans Heinzer, Thomas Steuber pages 668-672 Abstract | Full Text | Full-Text PDF (155 KB)
Kidney cancer in the elderly Ziya Kirkali pages 673-676 Abstract | Full Text | Full-Text PDF (132 KB)
Penile cancer Roberto Salvioni, Andrea Necchi, Luigi Piva, Maurizio Colecchia, Nicola Nicolai pages 677-685 Abstract | Full Text | Full-Text PDF (1332 KB)
Letter to Editor
To the Editor Philippe Edouard Spiess page 686 Full Text | Full-Text PDF (65 KB)
Survey Section Editorial Board page 687 Full-Text PDF (37 KB)
Urologic Oncology Survey
1. Commentary on Mortality results from a randomized prostate-cancer screening trial: Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD, Washington University School of Medicine, St. Louis, MO Daniel W. Lin pages 688-689 Abstract | Full Text | Full-Text PDF (101 KB)
Commentary on Improved sensitivity for detecting micrometastases in pelvic lymph nodes by real-time reverse transcriptase polymerase chain reaction (RT-PCR) compared with conventional RT-PCR in patients with clinically localized prostate cancer undergoing radical prostatectomy: Terakawa T, Miyake H, Kurahashi T, Furukawa J, Takenaka A, Fujisawa M, Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan Daniel W. Lin pages 689-690 Abstract | Full Text | Full-Text PDF (87 KB)
Commentary on Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer: Attard G, Reid AH, A'Hern R, Parker C, Oommen NB, Folkerd E, Messiou C, Molife LR, Maier G, Thompson E, Olmos D, Sinha R, Lee G, Dowsett M, Kaye SB, Dearnaley D, Kheoh T, Molina A, de Bono JS, Royal Marsden National Health Service Foundation Trust, The Institute of Cancer Research, Sutton, Surrey, United Kingdom; Cougar Biotechnology, Los Angeles, CA Daniel W. Lin pages 690-691 Abstract | Full Text | Full-Text PDF (85 KB)
Commentary on Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS, Division of Urologic Oncology, New York University School of Medicine, New York, NY Daniel W. Lin page 691 Abstract | Full Text | Full-Text PDF (71 KB)
Commentary on Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer: Morris MJ, Huang D, Kelly WK, Slovin SF, Stephenson RD, Eicher C, Delacruz A, Curley T, Schwartz LH, Scher HI, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Weill Medical College of Cornell University, New York, NY Daniel W. Lin page 692 Abstract | Full Text | Full-Text PDF (75 KB)
Commentary on Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95: Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Storkel S, Willich N, Semjonow A, Souchon R, Stockle M, Rube C, Weissbach L, Althaus P, Rebmann U, Kalble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K, Department of Radio Oncology, University Hospital Ulm, Ulm, Germany Joseph Smith pages 692-693 Abstract | Full Text | Full-Text PDF (85 KB)
Commentary on Salvage robotic-assisted radical prostatectomy: Initial results and early report of outcomes: Boris RS, Bhandari A, Krane LS, Eun D, Kaul S, Peabody JO, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI Joseph Smith pages 693-694 Abstract | Full Text | Full-Text PDF (84 KB)
Commentary on Final outcomes of patients with low-risk prostate cancer suitable for active surveillance but treated surgically: Louie-Johnsun M, Neill M, Treurnicht K, Jarmulowicz M, Eden C, Department of Laparoscopic Urology, Royal Surrey County Hospital, Guildford, Surrey and The Hampshire Clinic, Basingstoke, Hampshire, UK Joseph Smith page 694 Abstract | Full Text | Full-Text PDF (73 KB)
Commentary on High-intensity focused ultrasound for prostate cancer: Comparative definitions of biochemical failure: Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF, Harlaching Hospital, Munich, Germany Joseph Smith pages 694-695 Abstract | Full Text | Full-Text PDF (84 KB)
Commentary on Pelvic Lymph Node Dissection in Prostate Cancer: Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE, Department of Urology, Vita-Salute University, Milan, Italy Joseph Smith page 695 Abstract | Full Text | Full-Text PDF (71 KB)
Information for Authors page IBC Full-Text PDF (36 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
